CLINDAMYCIN-MIP 150mg / ml solution for injection / infusion medication leaflet

J01FF01 clindamycin • Antiinfectives for systemic use | Macrolides, lincosamides and streptogramins | Lincosamides

Clindamycin is an antibiotic used to treat a wide range of bacterial infections, including skin, bone, joint, and respiratory tract infections. It works by inhibiting bacterial protein synthesis, thereby stopping bacterial growth.

The medication is available in the form of capsules, injectable solutions, or topical gels, depending on the type and severity of the infection. It is important to follow your doctor's instructions and complete the full course of treatment to prevent the development of bacterial resistance.

Side effects may include nausea, diarrhea, abdominal pain, or skin rashes. In rare cases, clindamycin use may lead to pseudomembranous colitis, a serious condition requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver or kidney diseases, to ensure the safe use of clindamycin.

General data about CLINDAMYCIN-MIP 150mg / ml

Substance: clindamycin

Date of last drug list: 01-04-2026

Commercial code: W56621003

Concentration: 150mg / ml

Pharmaceutical form: solution for injection / infusion

Quantity: 1

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: CHEPHASAAR CHEM. - PHARMA FABRIK GMBH - GERMANIA

Holder: MIP PHARMA GMBH - GERMANIA

Number: 3331/2011/03

Shelf life: 2 years

Concentrations available for clindamycin

100mg, 150mg, 150mg/ml, 300mg, 300mg/2ml, 600mg

Other substances similar to clindamycin